USANA Health Sciences (USNA) Tops Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $19.20 +1.59%
Revenue Growth %: +0.0%
Financial Fact:
Interest income: 338K
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +0.0%
Financial Fact:
Interest income: 338K
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $1.36, $0.06 better than the analyst estimate of $1.30. Revenue for the quarter came in at $274.4 million versus the consensus estimate of $268.06 million.
GUIDANCE:
USANA Health Sciences sees FY2021 EPS of $5.80-$6.00, versus the consensus of $5.93. USANA Health Sciences sees FY2021 revenue of $1.18-1.2 billion, versus the consensus of $1.19 billion.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- KeyBanc Upgrades Nucor (NUE) to Overweight
- Green Dot and CommerceOne shareholders approve acquisition deal
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
